Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China flag China · Delayed Price · Currency is CNY
29.48
+0.05 (0.17%)
Sep 28, 2026, 4:00 PM EDT

SHA:688273 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
367.05816.45461.56991.631,176272.62
Trading Asset Securities
356.03-433.42105.6540-
Cash & Short-Term Investments
723.07816.45894.981,0971,216272.62
Cash Growth
-9.54%-8.77%-18.44%-9.75%345.98%81.97%
Accounts Receivable
37.9927.9117.7911.4126.8410.18
Other Receivables
0.650.741.161.471.460.3
Receivables
38.6328.6618.9412.8828.310.48
Inventory
81.3271.9973.0555.0268.5938.49
Prepaid Expenses
0.110.110.16---
Other Current Assets
2213.6114.526.677.919.69
Total Current Assets
865.13930.811,0021,1721,321341.28
Property, Plant & Equipment
464.47470.73327.42207.59154.73123.82
Long-Term Investments
128.17100.0898.7379.70.560.44
Goodwill
41.2341.2341.90.910.910.91
Other Intangible Assets
44.7549.5755.6131.2118.57.19
Long-Term Deferred Tax Assets
21.0817.939.499.996.146.47
Long-Term Deferred Charges
17.0417.548.135.276.598.03
Other Long-Term Assets
30.051.383.6927.43.880.59
Total Assets
1,6121,6291,5471,5341,512488.74

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
16.4814.1717.049.1612.5713.09
Accrued Expenses
18.0633.9737.6523.9726.632.64
Short-Term Debt
17.9213.17.01---
Current Portion of Leases
3.663.842.946.131.442.12
Current Income Taxes Payable
0.851.140.683.459.265.12
Current Unearned Revenue
43.8951.6151.2745.6647.9833.3
Other Current Liabilities
121.12102.9446.3844.8625.713.85
Total Current Liabilities
221.98220.78162.96133.24123.55100.11
Long-Term Leases
6.99.490.652.377.994.1
Long-Term Unearned Revenue
15.7215.7815.9417.756.0310.44
Long-Term Deferred Tax Liabilities
2.573.685.465.254.391.36
Other Long-Term Liabilities
8.329.9414.64---
Total Liabilities
255.48259.67199.66158.6141.96116.01

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
100100100100.6210075
Additional Paid-In Capital
986.86984.66984.54999.45982.792.55
Retained Earnings
301.9314.07279.91276.8267.48195.95
Treasury Stock
-53.58-53.58-52.25-31.09--
Total Common Equity
1,3351,3451,3121,3461,350363.5
Minority Interest
21.2724.4434.7629.5419.779.24
Shareholders' Equity
1,3561,3701,3471,3751,370372.74
Total Liabilities & Equity
1,6121,6291,5471,5341,512488.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
28.4826.4210.68.519.436.22
Net Cash (Debt)
694.59790.03884.381,0891,206266.4
Net Cash Growth
-10.92%-10.67%-18.77%-9.75%352.86%86.98%
Net Cash Per Share
7.108.088.9810.8914.483.55
Filing Date Shares Outstanding
97.8197.8197.8199.5110075
Total Common Shares Outstanding
97.8197.8197.86100.6210075
Working Capital
643.16710.03838.71,0391,197241.17
Book Value Per Share
13.6513.7513.4113.3713.504.85
Tangible Book Value
1,2491,2541,2151,3141,331355.4
Tangible Book Value Per Share
12.7712.8212.4113.0613.314.74
Buildings
348.78348.78112.1112.1112.1112.1
Machinery
62.2460.8753.5344.3937.3121.95
Construction In Progress
109.31105.8820377.0419.99-